Your Vision, Our Innovations, Clinical Reality!

Richard is a seasoned theoretical and information physicist with 15+ years of experience in both academic and industrial research and development in computational biology and preclinical drug discovery. Specifically, he is specialized in information theory approach for drug discovery, fragment-based aptamer design, pharmacokinetic and pharmacodynamic modeling and simulations. He has published over 30 peer-reviewed papers and book chapters. He also owns 8 patents. He has headed a computational group of an Edmonton-based natural therapy company to develop company’s core technology for combination drug discovery using systems pharmacology and information theory approach. He co-founded two biotech companies.

Jack has been a professor of physics of the University of Alberta, Canada since 1988 and professor of bioengineering at the Polytechnic University of Turin, Italy since 2017. Between 2005 and 2020 he held the prestigious Allard Chair in Experimental Oncology at the Cross Cancer Institute. He held visiting professorship and research positions in China, Germany, France, Israel, Denmark, Belgium, Poland and Switzerland. He has published 600 journal papers, and 12 books. He obtained 7 patents in the USA, Canada, EU, South Korea, Brazil, Japan and Singapore. His received over 100 research grants from Canadian, US and European funding agencies. He is on the editorial board of 30 international journals. His molecular biophysics group performs research in drug design for a spectrum of applications. One of the drugs (CCI-001) he designed is in clinical trials for metastatic bladder cancer. He was a founding member of 3 spin-off companies.